Following the recent episode of the “rosuvastatin-JUPITER controversy” in the Archives, a major issue—as correctly underlined by Pippin—is that most people taking a statin for the prevention of cardiovascular diseases actually do not benefit from this treatment. We also agree that the JUPITER controversy unfortunately masked the major question of how to efficiently reduce cardiovascular risk without taking cholesterol-lowering drugs.
Pippin proposes the adoption of a plant-based dietary pattern. We again agree that this strategy is probably better—both in terms of clinical efficiency and “side effects”—than taking a statin. Pippin backs his recommendation on the basis of the 52-nation INTERHEART study and the 2006 American Heart Association (AHA) Diet and Lifestyle Recommendations, as cited in his letter. However, evidence-based preventive medicine should primarily be based on randomized clinical trials. Neither INTERHEART (a case-control study) nor the 2006 AHA Recommendations (in which no clinical trial was cited) provide convincing evidence. This would reinforce the widespread idea that in the supposed absence of dietary trial, it is reassuring to use cholesterol-lowering drugs, despite the present statin controversy.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.